0001493152-23-024107.txt : 20230710 0001493152-23-024107.hdr.sgml : 20230710 20230710154744 ACCESSION NUMBER: 0001493152-23-024107 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230410 FILED AS OF DATE: 20230710 DATE AS OF CHANGE: 20230710 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: He Junli CENTRAL INDEX KEY: 0001728598 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-35853 FILM NUMBER: 231079698 MAIL ADDRESS: STREET 1: C/O NO.1, COUNTRY GARDEN ROAD STREET 2: BEIJIAO TOWN, SHUNDE DISTRICT CITY: FOSHAN STATE: F4 ZIP: 528300 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Biostage, Inc. CENTRAL INDEX KEY: 0001563665 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 455210462 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 84 OCTOBER HILL ROAD STREET 2: SUITE 11 CITY: HOLLISTON STATE: MA ZIP: 01746 BUSINESS PHONE: (774) 233-7300 MAIL ADDRESS: STREET 1: 84 OCTOBER HILL ROAD STREET 2: SUITE 11 CITY: HOLLISTON STATE: MA ZIP: 01746 FORMER COMPANY: FORMER CONFORMED NAME: Harvard Apparatus Regenerative Technology, Inc. DATE OF NAME CHANGE: 20121204 4/A 1 ownership.xml X0407 4/A 2023-04-10 2023-04-12 0 0001563665 Biostage, Inc. BSTG 0001728598 He Junli C/O BIOSTAGE, INC., 84 OCTOBER HILL ROAD, SUITE 11 HOLLISTON, MA 01746 1 1 0 0 CEO 0 Stock Option (right to buy) 6.08 2023-04-10 4 A 0 267616 0 A 2033-04-10 Common Stock, par value $0.01 per share 267616 267616 D On April 12, 2023, the Reporting Person filed a Form 4 (the "Original Form 4"), which noted a stock option (right to buy) of 488,256 shares (also known as milestone options) of Biostage, Inc. On July 10, 2023, the Issuer and Reporting Person amended and corrected such option amount to 267,616 shares. This amendment is being filed to amend and restate the reporting of those stock options to report the corrected amount. Subject to continued employment or service through the applicable vesting dates, up to 267,616 shall vest in two increments, each for 133,808 shares, each such vesting subject to certain performance milestones set by the Board of Directors of the Issuer. /s/ Joseph Damasio, by power of attorney 2023-07-10